Publications by authors named "Mark Bray"

28Publications

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.

Lancet 2020 08 14;396(10248):381-389. Epub 2020 Jul 14.

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Oxford, UK; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, Oxford, UK. Electronic address:

View Article and Find Full Text PDF
August 2020

Author Correction: Fcmr regulates mononuclear phagocyte control of anti-tumor immunity.

Nat Commun 2019 Sep 3;10(1):4069. Epub 2019 Sep 3.

The Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.

View Article and Find Full Text PDF
September 2019

Fcmr regulates mononuclear phagocyte control of anti-tumor immunity.

Nat Commun 2019 06 18;10(1):2678. Epub 2019 Jun 18.

The Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.

View Article and Find Full Text PDF
June 2019

Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer.

Proc Natl Acad Sci U S A 2017 03 7;114(12):3127-3132. Epub 2017 Mar 7.

The Campbell Family Institute for Breast Cancer Research at Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 2M9

View Article and Find Full Text PDF
March 2017

Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts.

Oncotarget 2017 Jan;8(2):3064-3071

Ontario Cancer Institute and Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
January 2017

Targeting Mitosis in Cancer: Emerging Strategies.

Mol Cell 2015 Nov;60(4):524-36

The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, 610 University Avenue, Toronto, ON M5G 2M9, Canada. Electronic address:

View Article and Find Full Text PDF
November 2015

Functional characterization of CFI-400945, a Polo-like kinase 4 inhibitor, as a potential anticancer agent.

Cancer Cell 2014 Aug 17;26(2):163-76. Epub 2014 Jul 17.

The Campbell Family Institute for Breast Cancer Research, 620 University Avenue, Toronto, ON M5G 2M9, Canada. Electronic address:

View Article and Find Full Text PDF
August 2014

2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.

Proc Natl Acad Sci U S A 2012 Dec 3;109(51):21034-9. Epub 2012 Dec 3.

Campbell Family Institute for Breast Cancer Research, University Health Network, Toronto, ON, Canada M5G 2C1.

View Article and Find Full Text PDF
December 2012

Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma.

Br J Haematol 2010 Aug 15;150(3):313-25. Epub 2010 Jun 15.

Division of Hematology and Oncology, Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

View Article and Find Full Text PDF
August 2010

Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors.

Bioorg Med Chem Lett 2007 Nov 19;17(21):5995-9. Epub 2007 Aug 19.

EntreMed Inc., 101 College Street, Toronto Medical Discovery Tower, Toronto, Ontario, Canada M5G1L7.

View Article and Find Full Text PDF
November 2007